Clinical Trials Directory

Trials / Completed

CompletedNCT03536702

Effect of Group Led Creative Writing on Mood in Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to determine whether creative writing in newly diagnosed cancer patients and those with recent progression in their disease will have a positive impact on their mental health. Using a randomized controlled trial approach, emotion thermometers will be employed to evaluate participants' responses on a number of domains, such as anxiety, depression, despair, and anger along with a series of survey questions to monitor changes in depressive and anxiety symptoms. Open-ended survey questions will be used to capture how a creative writing intervention impacts participants' experience of their illness. Melissa Greene's Write from the Heart program focuses more on creative writing rather than cancer focused topics. Patients in the intervention arm will complete -one and a half hour group sessions every two weeks over the span of 3 months. Participants in the active control arm will be provided a book (i.e., Writing Down Bones by Natalie Goldberg) about creative writing and will be asked to do activities for 1.5 hrs every 2 weeks for a period of 3 months.

Detailed description

Mental wellness before and after intervention in both arms. A validated Emotional Thermometer Scales will be used to predict changes in parameters reflecting participants' mental health pre- and post-intervention. Survey questions focused on symptoms of depression and anxiety will be used to monitor for changes in mental wellness pre- and post-intervention.

Conditions

Interventions

TypeNameDescription
OTHERCreative Writing WorkshopThis group will participate in a writing workshop in group sessions.
OTHERIndependent Writing - Control GroupThis group will receive a book for a self writing session.

Timeline

Start date
2018-03-28
Primary completion
2018-11-16
Completion
2018-11-16
First posted
2018-05-25
Last updated
2020-10-20
Results posted
2020-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03536702. Inclusion in this directory is not an endorsement.